Shanghai Junshi Biosciences (Stock Code: 1877, 688180) Announces 2025 Third Quarterly Results Briefing

Bulletin Express

Oct 21

Shanghai Junshi Biosciences Co., Ltd.* (Junshi Bio) has scheduled its 2025 third quarterly results briefing for 29 October 2025 (Wednesday), from 11:00 to 12:00, at the Shanghai Stock Exchange Roadshow Center. The company will issue its third quarter earnings report on the Shanghai Stock Exchange (www.sse.com.cn) on the same day.

Company representatives plan to discuss recent operating results and financial indicators during the session. Interested investors may submit questions online in advance through the “Pre-collection of Questions” section at the SSE Roadshow Center website or via the company’s email (info@junshipharma.com) between 22 October 2025 (Wednesday) and 16:00 on 28 October 2025 (Tuesday). Questions of general interest will be addressed in the scheduled briefing.

Participants from the company are expected to include an executive director, an independent non-executive director, the financial director, and the secretary of the board of directors. Updates from the briefing will be accessible for review on the SSE Roadshow Center website following the event.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1160317599"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1160317599\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1160317599?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-21 19:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1160317599","market":"hk","top_or_hot":-1,"title":"Shanghai Junshi Biosciences (Stock Code: 1877, 688180) Announces 2025 Third Quarterly Results Briefing","media":"Bulletin Express","content":"<p>Shanghai Junshi Biosciences Co., Ltd.* (Junshi Bio) has scheduled its 2025 third quarterly results briefing for 29 October 2025 (Wednesday), from 11:00 to 12:00, at the Shanghai Stock Exchange Roadshow Center. The company will issue its third quarter earnings report on the Shanghai Stock Exchange (www.sse.com.cn) on the same day.</p>\n<p>Company representatives plan to discuss recent operating results and financial indicators during the session. Interested investors may submit questions online in advance through the “Pre-collection of Questions” section at the SSE Roadshow Center website or via the company’s email (info@junshipharma.com) between 22 October 2025 (Wednesday) and 16:00 on 28 October 2025 (Tuesday). Questions of general interest will be addressed in the scheduled briefing.</p>\n<p>Participants from the company are expected to include an executive director, an independent non-executive director, the financial director, and the secretary of the board of directors. Updates from the briefing will be accessible for review on the SSE Roadshow Center website following the event.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Junshi Biosciences (Stock Code: 1877, 688180) Announces 2025 Third Quarterly Results Briefing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Junshi Biosciences (Stock Code: 1877, 688180) Announces 2025 Third Quarterly Results Briefing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-10-21 19:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Junshi Biosciences Co., Ltd.* (Junshi Bio) has scheduled its 2025 third quarterly results briefing for 29 October 2025 (Wednesday), from 11:00 to 12:00, at the Shanghai Stock Exchange Roadshow Center. The company will issue its third quarter earnings report on the Shanghai Stock Exchange (www.sse.com.cn) on the same day.</p>\n<p>Company representatives plan to discuss recent operating results and financial indicators during the session. Interested investors may submit questions online in advance through the “Pre-collection of Questions” section at the SSE Roadshow Center website or via the company’s email (info@junshipharma.com) between 22 October 2025 (Wednesday) and 16:00 on 28 October 2025 (Tuesday). Questions of general interest will be addressed in the scheduled briefing.</p>\n<p>Participants from the company are expected to include an executive director, an independent non-executive director, the financial director, and the secretary of the board of directors. Updates from the briefing will be accessible for review on the SSE Roadshow Center website following the event.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01877","symbol_name":"君实生物","start_time":0,"source_url":"","article_id":"1160317599","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1160317599","pubTimestamp":1761045127,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Junshi Biosciences Co., Ltd.* (Junshi Bio) has scheduled its 2025 third quarterly results briefing for 29 October 2025 (Wednesday), from 11:00 to 12:00, at the Shanghai Stock Exchange...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01877":"君实生物"},"translate_title":"上海君实生物（股票代码：1877,688180）公布2025年第三季度业绩说明会","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01877":1},"content_text":"Shanghai Junshi Biosciences Co., Ltd.* (Junshi Bio) has scheduled its 2025 third quarterly results briefing for 29 October 2025 (Wednesday), from 11:00 to 12:00, at the Shanghai Stock Exchange Roadshow Center. The company will issue its third quarter earnings report on the Shanghai Stock Exchange (www.sse.com.cn) on the same day.\nCompany representatives plan to discuss recent operating results and financial indicators during the session. Interested investors may submit questions online in advance through the “Pre-collection of Questions” section at the SSE Roadshow Center website or via the company’s email (info@junshipharma.com) between 22 October 2025 (Wednesday) and 16:00 on 28 October 2025 (Tuesday). Questions of general interest will be addressed in the scheduled briefing.\nParticipants from the company are expected to include an executive director, an independent non-executive director, the financial director, and the secretary of the board of directors. Updates from the briefing will be accessible for review on the SSE Roadshow Center website following the event.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}